cGAS-STING pathway
The cGAS-STING pathway, comprising cyclic guanosine monophosphate-adenosine monophosphate synthase (Cgas) and stimulator of interferon genes (Sting), is a crucial component of the innate immune response.
The cGAS-STING pathway, comprising cyclic guanosine monophosphate-adenosine monophosphate synthase (Cgas) and stimulator of interferon genes (Sting), is a crucial component of the innate immune response. This pathway is activated in response to the presence of cytosolic DNA, which can originate from pathogens or damaged host cells. Upon activation, Cgas synthesizes cyclic dinucleotides that bind to Sting, leading to the activation of downstream signaling cascades that promote the production of type I interferons and other proinflammatory cytokines. This response plays a significant role in anti-tumor immunity, making the cGAS-STING pathway a promising target for cancer immunotherapy.
Where the papers sit
15 papers from the last 6 months study cGAS-STING pathway directly · updated from PubMed 15 Nov 2026
Study type 0 clinical trials · 1 human data · 13 preclinical · 1 unclassified
Themes one subject
Those 15 are all about one subject.
-
Therapeutic cGAS-STING Modulation
Therapeutic cGAS-STING work is split between activating innate immunity for cancer vaccines and photo- or chemoimmunotherapy, and inhibiting it in sterile inflammation. Manganese and other nanoplatforms recur as ways to amplify cytosolic DNA sensing, oxidative stress, pyroptosis or ferroptosis in tumors. In traumatic brain injury, ischemic stroke, myocardial infarction, bone loss and disc degeneration, mitochondrial homeostasis, mitophagy and mtDNA-driven inflammation are recurring targets. cGAS/HDAC inhibitors and NAD+ support suppression, but disease-specific biomarkers and translation beyond animal models remain open.
Papers
The 15 papers from the last 6 months that study cGAS-STING pathway directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.
By theme
Therapeutic cGAS-STING Modulation (15)
- Pharmacological cGAS-STING pathway inhibition on neuroinflammation in animal models of traumatic brain injury: A systematic review and meta-analysis protocol. PloS one · 6 Nov 2026 PMID 42993726
- Cascade-Catalytic MnO2 Nanoreactor Amplifies Oxidative Stress and Activates cGAS-STING Pathway To Remodel the Immunosuppressive Microenvironment of Triple-Negative Breast Cancer. ACS applied materials & interfaces · 19 Oct 2026 PMID 42896505
- NAD+ Attenuates Neuroinflammation in Ischemic Stroke by Suppressing the cGAS- STING Pathway via Mitochondrial Homeostasis Restoration. Molecular neurobiology · 13 Oct 2026 PMID 42870203
- The cGAS-STING pathway in acute myocardial infarction: Biomarker discovery and mechanistic insights. PloS one · 18 Sept 2026 PMID 42758768
- Tumor Microenvironment-Triggered Nanocrystal-to-Nanocrystal Transformation for RNA-Boosted Photo-STING Therapy. Journal of the American Chemical Society · 9 Sept 2026 PMID 42714526
- Tumor microenvironment-responsive manganese nanoplatform amplifies cGAS-STING via metabolic-metal synergy for immunotherapy. Journal of controlled release : official journal of the Controlled Release Society · 23 Jul 2026 PMID 42492637
- An Orthogonal Nanoadjuvant-Based RSV Subunit Vaccine Unlocks Potent Immunity through a High-Entropy-like Immunostimulatory Effect. Journal of the American Chemical Society · 22 Jul 2026 PMID 42485602
- Dual-regulation of mitophagy and cytosolic mtDNA-induced inflammation for the treatment of inflammatory bone loss. Free radical biology & medicine · 18 Jul 2026 PMID 42471165
- Nanozyme-integrated hydrogel orchestrates mitochondrial quality control to counter inflammatory and oxidative milieu during disc degeneration. Journal of controlled release : official journal of the Controlled Release Society · 18 Jul 2026 PMID 42471059
- Intelligent metal-integrated hydrogels orchestrate pyroptosis and cGAS-STING for potentiated treatment of colorectal cancer peritoneal metastasis. Journal of controlled release : official journal of the Controlled Release Society · 15 Jul 2026 PMID 42456978
- A Skin and Tumor Dual-Permeable Tumoricidal Gel for cGAS-STING Activation-Enhanced Chemoimmunotherapy. ACS nano · 9 Jul 2026 PMID 42421302
- Design, Synthesis, and Pharmacological Evaluation of cGAS/HDAC Dual Inhibitors for Treatment of Autoimmune Diseases. Journal of medicinal chemistry · 10 Jun 2026 PMID 42268702
- NIR-Programmable Stealth 2D Black Phosphorus Nanobiointerfaces for Deep Tumor Penetration and Photoimmunotherapy. ACS nano · 5 Jun 2026 PMID 42246982
- An Engineered Microbial Nanohybrid for Enhanced Ferroptosis Immunotherapy via Hypoxia-Responsive Hydrogen Sulfide Generation and Mitophagy Inhibition. ACS nano · 5 Jun 2026 PMID 42246518
- CDK4/6 inhibition uncovers subtype-specific vulnerabilities and immune-related responses in esophageal squamous cell carcinoma. Cell death & disease · 29 May 2026 PMID 42215475
By study type
Human data, design not indexed (1)
- The cGAS-STING pathway in acute myocardial infarction: Biomarker discovery and mechanistic insights. PloS one · 18 Sept 2026 PMID 42758768
Preclinical: animal, cell and lab studies (13)
- Pharmacological cGAS-STING pathway inhibition on neuroinflammation in animal models of traumatic brain injury: A systematic review and meta-analysis protocol. PloS one · 6 Nov 2026 PMID 42993726
- Cascade-Catalytic MnO2 Nanoreactor Amplifies Oxidative Stress and Activates cGAS-STING Pathway To Remodel the Immunosuppressive Microenvironment of Triple-Negative Breast Cancer. ACS applied materials & interfaces · 19 Oct 2026 PMID 42896505
- NAD+ Attenuates Neuroinflammation in Ischemic Stroke by Suppressing the cGAS- STING Pathway via Mitochondrial Homeostasis Restoration. Molecular neurobiology · 13 Oct 2026 PMID 42870203
- Tumor Microenvironment-Triggered Nanocrystal-to-Nanocrystal Transformation for RNA-Boosted Photo-STING Therapy. Journal of the American Chemical Society · 9 Sept 2026 PMID 42714526
- Tumor microenvironment-responsive manganese nanoplatform amplifies cGAS-STING via metabolic-metal synergy for immunotherapy. Journal of controlled release : official journal of the Controlled Release Society · 23 Jul 2026 PMID 42492637
- An Orthogonal Nanoadjuvant-Based RSV Subunit Vaccine Unlocks Potent Immunity through a High-Entropy-like Immunostimulatory Effect. Journal of the American Chemical Society · 22 Jul 2026 PMID 42485602
- Dual-regulation of mitophagy and cytosolic mtDNA-induced inflammation for the treatment of inflammatory bone loss. Free radical biology & medicine · 18 Jul 2026 PMID 42471165
- Nanozyme-integrated hydrogel orchestrates mitochondrial quality control to counter inflammatory and oxidative milieu during disc degeneration. Journal of controlled release : official journal of the Controlled Release Society · 18 Jul 2026 PMID 42471059
- Intelligent metal-integrated hydrogels orchestrate pyroptosis and cGAS-STING for potentiated treatment of colorectal cancer peritoneal metastasis. Journal of controlled release : official journal of the Controlled Release Society · 15 Jul 2026 PMID 42456978
- A Skin and Tumor Dual-Permeable Tumoricidal Gel for cGAS-STING Activation-Enhanced Chemoimmunotherapy. ACS nano · 9 Jul 2026 PMID 42421302
- Design, Synthesis, and Pharmacological Evaluation of cGAS/HDAC Dual Inhibitors for Treatment of Autoimmune Diseases. Journal of medicinal chemistry · 10 Jun 2026 PMID 42268702
- NIR-Programmable Stealth 2D Black Phosphorus Nanobiointerfaces for Deep Tumor Penetration and Photoimmunotherapy. ACS nano · 5 Jun 2026 PMID 42246982
- An Engineered Microbial Nanohybrid for Enhanced Ferroptosis Immunotherapy via Hypoxia-Responsive Hydrogen Sulfide Generation and Mitophagy Inhibition. ACS nano · 5 Jun 2026 PMID 42246518
Unclassified: not yet indexed with MeSH (1)
- CDK4/6 inhibition uncovers subtype-specific vulnerabilities and immune-related responses in esophageal squamous cell carcinoma. Cell death & disease · 29 May 2026 PMID 42215475
Written from 15 PubMed abstracts, each one listed by PMID above. Published: 2026-06-16. Last written: 2026-09-20 by GPT. Drafted by language models from published abstracts; not medical advice.